HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
HUTCHMED (China) Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$14.18+0.13 (+0.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 27.3
- Dividend yield
- –
HUTCHMED (China) statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Market Cap | $2.47B | $166.30M |
| Enterprise Value | $1.24B | $87.12M |
| PE Ratio | 5.45 | 19.67 |
| PS Ratio | 4.51 | 3.60 |
| PB Ratio | 2.00 | 2.03 |
| P/TBV Ratio | 2.02 | 2.31 |
Enterprise value
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| EV / Sales | 2.26 | 2.43 |
Income (trailing twelve months)
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Revenue | $548.51M | $57.94M |
| Gross Profit | $212.16M | $90.47M |
| Operating Income | -$39.16M | -$21.49M |
| Pretax Income | $498.69M | -$14.72M |
| Net Income | $456.91M | -$22.46M |
| EBITDA | -$25.85M | -$17.14M |
| EPS (Diluted) | $0.52 | -$0.83 |
Margins
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Gross Margin | 38.7% | 52.3% |
| Operating Margin | -7.14% | -44.5% |
| Pretax Margin | 90.9% | -13.0% |
| Profit Margin | 83.3% | -39.2% |
| EBITDA Margin | -4.71% | -31.3% |
| FCF Margin | -14.4% | -8.85% |
Returns
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Return on Equity (ROE) | 45.7% | -53.2% |
| Return on Assets (ROA) | 30.2% | -41.0% |
| Return on Invested Capital (ROIC) | -363.9% | -32.2% |
| Return on Capital Employed (ROCE) | -2.72% | -38.0% |
Growth
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -13.0% | 6.01% |
| Net Income Growth (YoY) | 1111.0% | -37.7% |
| EPS Growth (YoY) | 1200.0% | -29.2% |
| Revenue Growth (3Y CAGR) | 8.76% | 2.25% |
| Revenue Growth (5Y CAGR) | 19.2% | 6.42% |
Balance sheet
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.37B | $62.64M |
| Total Debt | $118.13M | $120.13M |
| Net Cash (Debt) | $1.25B | $15.77M |
| Net Cash Per Share | $1.43 | $0.66 |
| Equity (Book Value) | $1.24B | $48.61M |
| Book Value Per Share | $1.42 | $1.36 |
| Tangible Book Value | $1.23B | $23.01M |
| Working Capital | $1.25B | $75.09M |
Financial position
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Current Ratio | 4.96 | 3.30 |
| Quick Ratio | 4.73 | 2.39 |
| Debt / Equity | 0.10 | 0.51 |
| Interest Coverage | -13.67 | -7.12 |
Cash flow (trailing twelve months)
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Operating Cash Flow | -$64.66M | -$12.39M |
| Capital Expenditures | -$14.15M | -$1.07M |
| Free Cash Flow | -$78.81M | -$20.34M |
| FCF Per Share | -$0.09 | -$0.42 |
Efficiency
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Asset Turnover | 0.36 | 0.38 |
| Inventory Turnover | 7.35 | 2.67 |
| Revenue Per Employee | $5.03M | $398.96K |
| Profits Per Employee | $4.19M | -$705.27K |
| Employee Count | 109 | 74 |
Dividends and yields
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Earnings Yield | 18.5% | -22.8% |
| FCF Yield | -3.19% | -9.02% |
| Buyback Yield | -0.06% | -0.73% |
| Shareholder Yield | -0.06% | 0.00% |
Shares
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Shares Outstanding | 872,328,000 | 58,139,000 |
| Shares Change (YoY) | 0.01% | 11.1% |
| Float | 868,522,000 | 49,154,900 |
| Shares Held by Insiders | 0.44% | 11.6% |
| Shares Held by Institutions | 0.51% | 59.4% |
Taxes
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Income Tax | $63.61M | $89.00K |
| Effective Tax Rate | 12.8% | 20.5% |
Scores
| Measure | HUTCHMED (China) | Industry median |
|---|---|---|
| Graham Number | $4.07 | $17.04 |
| Graham Upside | 43.7% | -44.3% |
| Altman Z-Score | 3.75 | -0.27 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from HUTCHMED (China)'s SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.